/Investor DB

Inveready Technology Investment Group — 2018 Investments

3 investments dated 2018 · listed companies and verified rows first · show all

Spiral Therapeuticsspiraltx.cominSeries A · Dec 2018 · $6M

Spiral Therapeutics is a clinical-stage pharmaceutical company developing therapies for balance disorders and hearing loss using its Minimally Invasive Cochlear System (MICS) drug delivery platform.

BiotechDigital HealthHealthtechMedical DevicesSouth San Francisco, US

Hugo Peris(Founder & CEO)inEugene de Juan(Executive Officer, Director)Lawrence Fritz(Director)

BoardWARREN THALER(Director)JEAN-FREDERIC PAULSEN(Director)Guy Nohra(Director)in

Co-investorsCatalio Capital ManagementLifelinkAlta PartnersCamden PartnersEsperante Ventures

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

ViniexportVoztelecom

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.